Webinar
Current solutions for menstrual health often only absorb symptoms rather than addressing the underlying issues, leaving many women with inadequate support during their menstrual cycles. This lack of effective treatment can perpetuate a cycle of discomfort and anxiety, impacting overall well-being. It's time to shift our approach and recognise menstruation-related discomfort as a health condition requiring comprehensive care. By breaking this cycle, we can help improve the quality of life for those affected.

By attending this webinar, we can help our patients experience a reduction in heavy menstrual bleeding, fostering a sense of confidence during their cycles. It’s time to prioritise effective treatment and acknowledge the importance of menstrual health in overall well-being.

Together, we can help break the cycle of suffering and promote a more comfortable experience for those who suffer with disruptive periods..

 Topics covered in this webinar will include:

  • Understanding the definition, symptoms and causes of heavy menstrual bleeding (HMB)
  • Know the impact HMB has on a patient's quality of life
  • Explain Evana® is specifically indicated for HMB and available OTC
  • Help to ease the monthly disruption to work, school or social events and reduce the anxiety that HMB can bring.

This is intended for healthcare professionals only.

Evana® Heavy Period Relief 500mg tablets. Tranexamic acid. Maxwellia Ltd. P. Reduction of heavy menstrual bleeding over several cycles in women with regular, 21-35 day cycles with no more than 3 day variation. 

For full information see: evanaperiods.com/hcp/evana/spc.
To register for the webinar, simply complete the form!
Our presenter will carry out a live Q&A, if you have any questions please let us know.
By ticking this box, you agree to receive emails from Citeline, C+D, and carefully selected partners
By completing this form you agree C+D and Glenmark may contact you directly about industry news, products, services and events that may be of interest. This is subject to Maxwellia's privacy policy and C+D's privacy policy

Copyright © 2023 C+D Intelligence UK Limited
C+D Intelligence UK Limited | Registered in England & Wales No. 13793264 | Registered office is 3 More London Riverside, London SE1 2AQ.